Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1670 participants.
Also called NCT06725810
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,670 participants
- Sponsor
- Registry
-
NCT06725810
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06725810. Randomized; no masking; primary purpose treatment. Start 2025-03-27 (actual); primary completion 2029-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
- Acronym
- CANNON
- Condition
- Chronic Kidney Disease Associated Anemia
- Intervention (Drug)
- Enarodustat
- Lead sponsor
- Shanghai Zhongshan Hospital
Record details
- Record id
cardio:ct-nct06725810- Content hash
ddf30100400d76c51ef7f50e60f2299535ae73a5faad371dacfc3bbfea210773